178 related articles for article (PubMed ID: 6110476)
1. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
Birnbaum RS; Muszynski M; Roos BA
Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of somatostatin-immunoreactivity in an adrenal pheochromocytoma and a thyroid medullary carcinoma (Sipple syndrome).
Bethge N; Ahuja S; Diel F; Usadel KH
Exp Clin Endocrinol; 1988 May; 91(2):217-22. PubMed ID: 2900771
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity and biological activity of immunoreactive somatostatin in medullary carcinoma of the thyroid.
Saito S; Saito H; Matsumura M; Ishimaru K; Sano T
J Clin Endocrinol Metab; 1981 Dec; 53(6):1117-22. PubMed ID: 6117566
[TBL] [Abstract][Full Text] [Related]
8. Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia.
Deftos LJ; Bone HG; Parthemore JG
J Clin Endocrinol Metab; 1980 Oct; 51(4):857-62. PubMed ID: 6106648
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
10. A carbohydrate-containing form of immunoreactive calcitonin in transplantable rat medullary thyroid carcinomas.
O'Neil JA; Birnbaum RS; Jacobson A; Roos BA
Endocrinology; 1981 Mar; 108(3):1098-100. PubMed ID: 7460837
[TBL] [Abstract][Full Text] [Related]
11. Cloning and biosynthetic studies of rat somatostatin.
Dixon JE; Andrews PC; Collier K; Deschenes R; Funckes C; Lorenz L; Magazin M; Minth CD; Nichols R; Tavianini M
Scand J Gastroenterol Suppl; 1983; 82():25-31. PubMed ID: 6138851
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin-like immunoreactivity in transplantable medullary carcinoma of rat thyroid: partial chromatographic and biological characterization.
Berelowitz M; Cibelius M; Szabo M; Frohman LA; Epstein S; Bell NH
Endocrinology; 1980 Nov; 107(5):1418-24. PubMed ID: 6107240
[TBL] [Abstract][Full Text] [Related]
13. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
Deftos LJ; Boorman GA; Roos BA
Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795
[No Abstract] [Full Text] [Related]
14. High plasma levels of immunoreactive somatostatin in transgenic mice expressing a metallothionein-somatostatin fusion gene.
Low MJ; Goodman RH; Brinster RL; Palmiter RD; Hammer RE; Habener JF
Trans Assoc Am Physicians; 1984; 97():205-9. PubMed ID: 6152571
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma and tumor somatostatin-like immunoreactivity in medullary thyroid carcinoma and small cell lung cancer.
Roos BA; Lindall AW; Ells J; Elde R; Lambert PW; Birnbaum RS
J Clin Endocrinol Metab; 1981 Feb; 52(2):187-94. PubMed ID: 6109732
[No Abstract] [Full Text] [Related]
16. Ontogeny of immunoreactive somatostatin in thyroid C cells from dogs and guniea pigs.
Kameda Y; Oyama H; Horino M
Anat Rec; 1984 Jan; 208(1):89-101. PubMed ID: 6143519
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin immunoreactive C cells in thyroid glands from various mammalian species.
Kameda Y; Oyama H; Endoh M; Horino M
Anat Rec; 1982 Oct; 204(2):161-70. PubMed ID: 6129819
[TBL] [Abstract][Full Text] [Related]
18. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
19. Melanin-producing medullary thyroid carcinoma with glandular differentiation.
Kimura N; Ishioka K; Miura Y; Sasano N; Takaya K; Mouri T; Kimura T; Nakazato Y; Yamada R
Acta Cytol; 1989; 33(1):61-6. PubMed ID: 2644744
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin-producing pancreatic somatostatinoma.
Galmiche JP; Chayvialle JA; Dubois PM; David L; Descos F; Paulin C; Ducastelle T; Colin R; Geffroy Y
Gastroenterology; 1980 Jun; 78(6):1577-83. PubMed ID: 6102950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
